Aethlon Medical Inc. (NASDAQ: AEMD) shares are trading down -7.08% at $2.1 at the time of writing after reporting First Patient Treated in First-in-Human Clinical
The markets are headed for a mixed start to the day. After several days of selloffs, things have stabilized with tech stocks leading the way.
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.